Pharmaceuticals

SNP Genotyping And Analysis Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the snp genotyping and analysis market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The SNP Genotyping And Analysis Market And What Value Is Projected For 2029?

The SNP genotyping and analysis market has experienced rapid expansion in recent years. It is projected to grow from $15.45 billion in 2024 to $18.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 19.7%. The market’s historic growth can be linked to factors such as increasing biomedical research funding, the expansion of personalized medicine initiatives, a rise in agricultural genomics, the substantial impact of chronic diseases, and the emergence of commercial genomic services.

The SNP genotyping and analysis market is projected to experience substantial expansion in the coming years. By 2029, its value is forecast to reach $38.58 billion, progressing at a compound annual growth rate (CAGR) of 20.2%. This expansion during the projection period stems from several factors, including the proliferation of population genomics initiatives, a heightened emphasis on diagnosing rare diseases, advancements in companion diagnostics and precision oncology, rising consumer interest in direct-to-consumer (DTC) genomics, and supportive regulatory frameworks for genomic medicine. Key trends for the forecast duration involve ongoing technological progress in genotyping platforms, their fusion with artificial intelligence and bioinformatics, increasing application in oncology investigations, broader use in forensic and ancestry examinations, and the creation of portable genotyping apparatuses.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp

What Factors Are Boosting The SNP Genotyping And Analysis Market?

The increasing prevalence of genetic diseases is anticipated to drive the expansion of the SNP genotyping and analysis market in the future. These conditions stem from DNA irregularities within an individual, which can be passed down from one or both parents or develop from mutations during cellular division. The rising impact of genetic diseases is attributed to heightened public awareness and advancements in diagnostic methods, resulting in a greater number of diagnoses and increased identification of these disorders. SNP genotyping and analysis assist in managing genetic diseases by pinpointing genetic variations linked to disease susceptibility, advancement, and medication effectiveness, thereby facilitating prompt diagnosis and tailored therapeutic approaches. An example is provided by a February 2024 report from Cystic Fibrosis Australia, a national organization in Australia for individuals with cystic fibrosis, which indicated that the population living with cystic fibrosis in Australia reached 3,738 in 2022, an increase from 3,616 cases in 2021. Consequently, the increasing prevalence of genetic diseases is fueling the expansion of the SNP genotyping and analysis market.

What Are The Core Segmentation Criteria In The SNP Genotyping And Analysis Market?

The snp genotyping and analysis market covered in this report is segmented –

1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood

2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies

3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock

4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions

Subsegments:

1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays

2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays

3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research

4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics

5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics

Which Emerging Trends Are Reshaping The SNP Genotyping And Analysis Market Landscape?

Leading companies operating within the SNP genotyping and analysis market are concentrating on developing technologically advanced solutions, such as agricultural large-scale low-pass whole genome sequencing, to tackle significant challenges in the molecular breeding genotyping of agricultural diploid species. Agricultural whole genome sequencing involves deciphering the complete genetic blueprint of crops or livestock to enhance traits like yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a China-based biotechnology firm, introduced a highly efficient comprehensive workflow solution for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). This solution comprises an automated full-process product portfolio covering DNA extraction, library preparation, sequencing, and SNP & InDel calling, specifically engineered for molecular breeding genotyping of agricultural diploid species. It incorporates advanced automation platforms and utilizes MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers to achieve ultra-high throughput and flexibility. The workflow additionally includes pig reference panels and data analysis software to streamline genotyping without requiring custom database creation.

Which Players Are Shaping The Competitive Landscape Of The SNP Genotyping And AnalysisXX Market?

Major companies operating in the SNP genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/snp-genotyping-and-analysis-global-market-report

What Regional Trends Are Shaping Growth In The SNP Genotyping And Analysis Market?

North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the SNP genotyping and analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24402&type=smp

Browse Through More Reports Similar to the Global SNP Genotyping And Analysis Market 2025, By The Business Research Company

Single Nucleotide Polymorphism Snp Genotyping Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report

Genotyping Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Genotyping Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795